Extracts of Ginkgo biloba leaves inhibit monoamine oxidase

Life Sciences

Volumn 58, Issue 16, 1996, Pages 1315-1321

  White, Helen L ^a,b   Scates, Philip W ^a   Cooper, Barrett R ^a  

^a Burroughs Wellcome Co   (United States)

^b NONE   (United States)

Author keywords

Anxiety; Ginkgo biloba; Monoamine oxidase; Stress

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ENZYME INHIBITOR; GINKGO BILOBA EXTRACT; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; PHENETHYLAMINE; RADIOISOTOPE; SEROTONIN;

ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CAPSULE; DRUG MECHANISM; DRUG STABILITY; MOLECULAR WEIGHT; NONHUMAN; PHARMACEUTICS; PLANT LEAF; RAT; STRESS; THERMOSTABILITY; TRANQUILIZING ACTIVITY;

ANIMALIA; GINKGO BILOBA; GYMNOMYZA SAMOENSIS;

EID: 0029988534     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00097-5     Document Type: Article

References (17)

1. F.V. DEFEUDIS, Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, 1-187, Elsevier, Paris (1991).
2. K. WEINGES, W. BÄHR and P. KLOSS, Justus Liebig's Ann. Chem. 724 214-216 (1969).
3. K. DRIEU, Presse Méd. 15, 1455-1457 (1986).
4. J. FILEP and É. FÖLDES-FILEP, Ginkgolides - Chemistry, Biology, Pharmacology and Clinical Perspectives, P. Braquet (ed), 151-159, J.R. Prous Science Publ., S.A. (1988).
5. M. SÁNCHEZ CRESPO and S. FERNÁNDEZ-GALLARDO, J. Lipid Mediators 4 127-143 (1991).
6. V.D. PETKOV, C. HADJIIVANOVA, V.V. PETKOV, S. MILANOV, N. VISHEVA, N. BOYADJIEVA, Phytother. res. 7 139-145 (1993).
7. R.D. PORSOLT, P. MARTIN, A. LENÈGRE, S. FROMAGE and K. DRIEU, Pharmac. Biochem. Behav. 36 963-971 (1990).
8. J.R. RAPIN, I. LAMPROGLOU, K. DRIEU and F.V. DEFEUDIS, Gen Pharmac 25 1009-1016 (1994).
9. M. NÖLDNER and S.S. CHATTERJEE, International Patent A61K31/365, 35/78, WO 93/12784, Willmar Schwabe Gmbh & Co.(1993).
10. E. MIDDLETON, Jr. and C. KANDASWAMI, The Flavonoids: Advances in Research Since 1986, J.B. Harborne (ed), Ch. 15, Chapman & Hall, London (1993).
11. A.E. HAGERMAN and L.G. BUTLER, J. Biol. Chem. 256 4494-4497 (1981).
12. D.L. MURPHY, T. SUNDERLAND and R.M. COHEN, Psychiatr Clin. North Am. 7 549-562 (1984).
13. H.L. WHITE and A.T. GLASSMAN, J. Neurochem. 29 987-997 (1977).
14. G. RACAGNI, N. BRUNELLO and R. PAOLETTI, Presse Méd. 15 1488-1490 (1986).
15. W. HAEFELY, W.P. BURKARD, A.M. CESURA, R. KETTLER, H.P. LOREZ, J.R MARTIN, J.G. RICHARDS, R. SCHERSCHLICHT and M. DA PRADA, Psychopharmacol. 106 6S-14S (1992).
16. M. AUGUET, F.V. DEFEUDIS and F. CLOSTRE, Gen. Pharmacol 13 169-171 (1982).
17. T.M. ITIL, E. ERALP, E. TSAMBIS, K.Z. ITIL and U. STEIN, Amer J. Therapeu., in press (1995).